患者-人工瓣膜不匹配降低远期生存:FinnValve注册研究启示
该研究基于芬兰全国FinnValve注册数据,纳入4097例使用带支架生物瓣行外科主动脉瓣置换术(SAVR)的患者,评估患者-人工瓣膜不匹配(PPM)的发生率及其对生存和再干预的影响。
要点
- SAVR术后PPM总体发生率为46.0%,重度PPM占7.2%。
- 重度PPM与5年全因死亡率升高独立相关(校正HR 1.72)。
- ≥70岁患者中任何PPM及重度PPM均增加5年死亡风险。
核心结论
- SAVR术后重度PPM对生存有负面影响,在老年患者中PPM的影响不应被忽视。
研究设计与样本
- 基于芬兰全国FinnValve注册的回顾性队列研究,纳入4097例使用带支架生物瓣行SAVR(伴或不伴心肌血运重建)的患者。
- PPM根据文献来源的有效开口面积(EOA)计算并分级:中度(EOA 0.65-0.85 cm2/m2)或重度(EOA ≤0.65 cm2/m2)。
主要发现
- PPM总体发生率为46.0%,其中中度38.8%(n=1579),重度7.2%(n=297)。
- 时间趋势分析显示PPM比例从2009年的74%显著下降至2017年的18%(P < .01)。
- 重度PPM与5年全因死亡率升高相关(校正HR 1.72;95%CI 1.07-2.76;P = .02)。
- 重度PPM与再次主动脉瓣置换风险增加无关(校正HR 5.90;95%CI 0.95-36.5;P = .06)。
- 在≥70岁患者亚组中,与无PPM相比,任何PPM(校正HR 1.23;95%CI 1.05-1.45;P = .01)和重度PPM(HR 1.53;95%CI 1.17-2.00;P < 0.01)均与5年死亡风险增加相关。
临床怎么用
- SAVR术中应关注并尽量避免重度PPM,尤其在老年患者中。
- 对于存在重度PPM风险的患者,应考虑选择有效开口面积更大的瓣膜或替代干预方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of patient-prosthesis mismatch (PPM) on long-term outcome after surgical aortic valve replacement (SAVR) is controversial. We sought to investigate the incidence of PPM and its impact on survival and reinterventions in a Finnish nationwide cohort. METHODS: In the context of the nationwide FinnValve registry, we identified 4097 patients who underwent SAVR with a stented bioprosthesis with or without myocardial revascularization. The indexed effective orifice areas (EOAs) of surgical bioprostheses were calculated using literature-derived EOAs. PPM was graded as moderate (EOA 0.65-0.85 cm2/m2) or severe (EOA ≤0.65 cm2/m2). RESULTS: The incidence of PPM was 46.0%. PPM was moderate in 38.8% (n = 1579) patients and severe in 7.2% (n = 297) patients. Time-trend analysis showed that the proportion of PPM decreased significantly from 74% in 2009 to 18% in 2017 (P < .01). Severe PPM was associated with increased 5-year all-cause mortality (adjusted hazard ratio [HR], 1.72; 95% confidence interval [CI], 1.07-2.76; P = .02). Severe PPM was not associated with an increased risk of repeat AVR (adjusted HR, 5.90; 95% CI, 0.95-36.5; P = .06). In a subanalysis of patients greater than or equal to 70 years of age, in comparison with no PPM, any PPM (adjusted HR, 1.23; 95% CI, 1.05-1.45; P = .01) and severe PPM (HR, 1.53; 95% CI, 1.17-2.00; P < 0.01) were associated with increased risk of 5-year mortality. CONCLUSIONS: Severe PPM after SAVR had a negative impact on survival. This study demonstrated that the effects of PPM should not be overlooked in elderly undergoing SAVR.
引用
- Dahlbacka S, Laakso T, Kinnunen EM, et al. Patient-Prosthesis Mismatch Worsens Long-Term Survival: Insights From the FinnValve Registry. Ann Thorac Surg. 2020. PMID: 32805269. doi:10.1016/j.athoracsur.2020.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。